Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002264784 | SCV002546465 | pathogenic | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2022-07-05 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.140_150del (p.Leu47fs) is a frameshift variant that is predicted to undergo nonsense mediated decay (PVS1). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). Frameshift variant downstream of c.98 (in transcript NM_001754.5) (PM5_supporting). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PVS1, PM2_supporting and PM5_supporting. |
Labcorp Genetics |
RCV001381113 | SCV001579365 | pathogenic | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2023-03-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu47Glnfs*87) in the RUNX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RUNX1 are known to be pathogenic (PMID: 18723428, 24100448). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RUNX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1069299). For these reasons, this variant has been classified as Pathogenic. |